Inventor · disambiguated record
Huai-Hung Kao
Also filed as: KAO HUAI-HUNG · KAO HUAI-HUNG D · KAO HUAI-HUNG DANNY
15 granted patents·29 pending applications·290 citations·filing 1998–2020
95Inventor score
Files withENDO PHARMACEUTICALS INC16PURDUE PHARMA LP15KAO HUAI-HUNG4ENDO PHARMACEUTICALS INC A DEL2PENWEST PHARMACEUTICALS COMPAN2
Top patents by PatentIndex Score
44 records- 0198US8969369B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2013·Granted Mar 3, 2015·43 cites·30 claims
- 0296US9168252B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2015·Granted Oct 27, 2015·12 cites·30 claims
- 0396US9161937B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2015·Granted Oct 20, 2015·14 cites·30 claims
- 0496US9056051B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2014·Granted Jun 16, 2015·17 cites·42 claims
- 0596US8309122B2Oxymorphone controlled release formulationsKAO HUAI-HUNG·Filed 2007·Granted Nov 13, 2012·49 cites·20 claims
- 0695US9084729B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2013·Granted Jul 21, 2015·14 cites·42 claims
- 0794US9511066B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2016·Granted Dec 6, 2016·7 cites·30 claims
- 0894US9480685B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2016·Granted Nov 1, 2016·7 cites·30 claims
- 0994US9358230B1Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2016·Granted Jun 7, 2016·7 cites·30 claims
- 1094US9345701B1Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2016·Granted May 24, 2016·7 cites·30 claims
- 1194US7276250B2Sustained release formulations of oxymorphonePENWEST PHARMACEUTICALS COMPAN·Filed 2002·Granted Oct 2, 2007·64 cites·16 claims
- 1293US9283221B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2015·Granted Mar 15, 2016·7 cites·30 claims
- 1393US9283216B2Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2015·Granted Mar 15, 2016·7 cites·30 claims
- 1478US2009192183A1Oxymorphone Controlled Release FormulationsENDO PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1576US9820982B2Oxymorphone controlled release formulationsKAO HUAI-HUNG·Filed 2002·Granted Nov 21, 2017·3 cites·71 claims
- 1676US2008262013A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1775US2021008063A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1875US2015011577A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1974US2018338967A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2073US2019111051A1Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 2171US6168805B1Aqueous process for manufacturing paroxetine solid dispersionsENDO PHARMACEUTICALS INC·Filed 1998·Granted Jan 2, 2001·32 cites·33 claims
- 2271US2014134250A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2371US2018169090A1Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 2468US2008069881A1Abuse-resistant controlled-release opioid dosage formENDO PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2567US2013172382A1Abuse-resistant controlled-release opioid dosage formENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2667US2017014405A1Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 2767US2017014406A1Abuse-resistant controlled-release opioid dosage formPURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 2866US2016136152A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2965US2012252832A1Abuse-resistant controlled-release opioid dosage formCARUSO FRANK S·Filed 2012·Application pending·0 cites
- 3065US2008050431A1Sustained release formulations of oxymorphonePENWEST PHARMACEUTICALS COMPAN·Filed 2007·Application pending·0 cites
- 3157US2003065002A1Abuse-resistant controlled-release opioid dosage formENDO PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3254US2013209561A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3351US2012231075A1Abuse-resistant opioid dosage formKAO HUAI-HUNG·Filed 2012·Application pending·0 cites
- 3451US2012237603A1Abuse-resistant opioid dosage formKAO HUAI-HUNG·Filed 2012·Application pending·0 cites
- 3551US2005169990A1Controlled release dosage forms using acrylic polymer, and process for makingFiled 2004·Application pending·0 cites
- 3650US2007281017A1Sustained release oxycodone composition with acrylic polymer and metal hydroxideENDO PHARMACEUTICALS INC A DEL·Filed 2006·Application pending·0 cites
- 3750US2007281016A1Sustained release oxycodone composition with acrylic polymer and surfactantENDO PHARMACEUTICALS INC A DEL·Filed 2006·Application pending·0 cites
- 3850US2011135731A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3949US2011020444A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4047US2009018154A1Opioid and methods of making and using the sameENDO PHARMACEUTICALS INC A COR·Filed 2008·Application pending·0 cites
- 4146US2003004177A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4246US2022105085A1Abrasion-resistant opioid formulations which resist abuse and include a sequestered opioid antagonistRELMADA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4341US2003064122A1Abuse resistant pharmaceutical composition containing capsaicinENDO PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4440US2017326134A1Abrasion-Resistant Opioid FormulationsRELMADA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Huai-Hung Kao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →